Evaluation of different ovarian stimulation protocols for in vitro fertilization
- PMID: 7502685
- DOI: 10.3109/09513599509160198
Evaluation of different ovarian stimulation protocols for in vitro fertilization
Abstract
In this study we evaluated retrospectively the efficacy of five different ovarian stimulation protocols in an in vitro fertilization program, in which 512 women were involved. Ovulation was induced by the following protocols: group I (271 cycles): buserelin short protocol (1 mg/day, intranasally) with human menopausal gonadotropin/human chorionic gonadotropin (hMG/hCG); group II (45 cycles): buserelin (short protocol) with pure follicle stimulating hormone (p-FSH)/hMG/hCG; group III (24 cycles): clomiphene citrate (100 mg/day) with hMG/hCG; group IV (122 cycles): hMG (3 ampules/day) and hCG; group V (113 cycles): hMG/hCG and prednisolone (7.5 mg/day) after cycle programming with oral contraceptives. The lowest cancellation rate (3.3%) was noted in group I, followed by group V (9.7%). The highest number of follicles was observed in groups I (8.3 +/- 0.3; mean +/- SEM) and V (7.8 +/- 0.5). Also, more oocytes were retrieved in group I (7.2 +/- 0.3, p < 0.001), which were of good quality based on oocyte maturity as well as on the fertilization rate, and more embryos (4.5 +/- 0.3, p < 0.05) were developed. The correlation between estradiol and the total follicular volume on the day of hCG administration was also examined in the five groups. The best correlation (r = 0.6502) was found in group I, followed by group V (r = 0.5810). Significant differences were observed in the five groups with regard to the number of hMG ampules administered (p < 0.0001, F = 15.393) and the stimulation days (p < 0.0001, F = 35.32). Sixty-six clinical pregnancies were achieved: 37 (17.5%) in group I, seven (25.9%) in group II, one (10%) in group III, ten (15.6%) in group IV and 11 (15.5%) in group V (differences were not statistically significant). In conclusion, all five protocols were satisfactory in ovarian stimulation for in vitro fertilization, and gonadotropin releasing hormone (GnRH) analogs seemed to be more advantageous by reducing the cancellation rate, enhancing the number of oocytes retrieved and embryos developed and by improving the pregnancy rates.
Similar articles
-
Do the suppression criteria in GnRH-a cycles predict in vitro fertilization outcome?Gynecol Endocrinol. 1995 Jun;9(2):91-6. doi: 10.3109/09513599509160196. Gynecol Endocrinol. 1995. PMID: 7502695
-
Programmed oocyte retrieval: clinical and biological effects of oral contraceptives administered before in vitro fertilization.Gynecol Endocrinol. 1989 Jun;3(2):107-15. doi: 10.3109/09513598909152457. Gynecol Endocrinol. 1989. PMID: 2816477 Clinical Trial.
-
In vitro fertilization with low-dose clomiphene citrate stimulation in women who respond poorly to superovulation.J Assist Reprod Genet. 1997 Oct;14(9):503-7. doi: 10.1023/a:1021171225322. J Assist Reprod Genet. 1997. PMID: 9401867 Free PMC article.
-
Controlled ovarian hyperstimulation for the new reproductive technologies.Acta Eur Fertil. 1989 Jul-Aug;20(4):217-21. Acta Eur Fertil. 1989. PMID: 2519574 Review.
-
In vitro fertilisation. A review of drug therapy and clinical management.Drugs. 1996 Sep;52(3):313-43. doi: 10.2165/00003495-199652030-00002. Drugs. 1996. PMID: 8875126 Review.
Cited by
-
Analysis of implantation in assisted reproduction through the use of serial human chorionic gonadotropin measurements.J Assist Reprod Genet. 1998 Sep;15(8):496-503. doi: 10.1023/a:1022534521019. J Assist Reprod Genet. 1998. PMID: 9785197 Free PMC article.
-
Cytokines in the human ovary: presence in follicular fluid and correlation with leukotriene B4.J Assist Reprod Genet. 1998 Feb;15(2):93-8. doi: 10.1007/BF02766833. J Assist Reprod Genet. 1998. PMID: 9513849 Free PMC article.
-
Oral contraceptive pill, progestogen or oestrogen pretreatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques.Cochrane Database Syst Rev. 2017 May 25;5(5):CD006109. doi: 10.1002/14651858.CD006109.pub3. Cochrane Database Syst Rev. 2017. PMID: 28540977 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources